Aptevo Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $19.3M | $30.4M | $30.6M |
| FY2019 | — | $11.8M | $12.4M |
| FY2020 | $28.2M | $16.6M | $40.0M |
| FY2021 | $3.7M | $1.2M | $45.0M |
| FY2022 | $1.5M | $18.0M | $22.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $19.3M | $30.4M | $30.6M |
| FY2019 | — | $11.8M | $12.4M |
| FY2020 | $28.2M | $16.6M | $40.0M |
| FY2021 | $3.7M | $1.2M | $45.0M |
| FY2022 | $1.5M | $18.0M | $22.6M |